key: cord-1007466-uvg3xh25
authors: Testori, Alberto; Perroni, Gianluca; Voulaz, Emanuele; Crepaldi, Alessandro; Alloisio, Marco
title: Pulmonary Lobectomy after COVID-19
date: 2020-09-25
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2020.08.004
sha: bb5d1723ef77a210a11c57c38721f45529ff5f01
doc_id: 1007466
cord_uid: uvg3xh25

Concomitant Coronavirus disease 19 (COVID-19) is a major risk factor for complications in any type of surgical procedures especially in thoracic surgery were the primary organ involved, lung, is manipulated in order to perform parenchymal resection. However, it is not clear if previous infection from acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to increased morbidity and mortality for subsequent procedures once radiological resolution is achieved. In this first report, a young patient with lung cancer successfully underwent a right upper lobectomy for primary adenocarcinoma by VATS with no complication in the early postoperative phase. Rapid spread of SARS-CoV-2 increased number of patients presented at emergency department with respiratory distress related to COVID-19. More chest scans are performed along with nasal swab to correctly diagnose the novel syndrome, therefore chances to detect lung nodules increase and management of those patients may be difficult. When concomitant, COVID-19 increase complications of surgical procedure because subsequent immune impairment. However, no data are available whether or not previous infection generate persistent risk. We present first case of successful pulmonary lobectomy for lung cancer in patient with previous history of COVID-19.

Rapid spread of SARS-CoV-2 increased number of patients presented at emergency department with respiratory distress related to COVID-19. More chest scans are performed along with nasal swab to correctly diagnose the novel syndrome, therefore chances to detect lung nodules increase and management of those patients may be difficult. When concomitant, COVID-19 increase complications of surgical procedure because subsequent immune impairment. However, no data are available whether or not previous infection generate persistent risk. We present first case of successful pulmonary lobectomy for lung cancer in patient with previous history of COVID-19.

A 46 years old male with previous history of 40 pack/years smoking came to our emergency department for worsening dyspnea and fever. A chest x-ray was performed, showing diffuse bilateral opacities with peripheral distribution. A subsequent computed tomography (CT) chest scan revealed peripheral bilateral ground-glass opacity (GGO) with crazy paving appearance plus a 40 mm nodule in the right upper lobe. A nasal swab was performed and tested positive for SARS-coV-2, diagnosis of COVID-19 was made. Overall conditions were good and intensive care unit (ICU) was not necessary. 

Extraordinary emergency measures set up by a Breast Unit to prevent COVID-19: Report of our experience

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)

The clinical dynamics of 18 cases of COVID-19 outside of Wuhan

BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee

Guidelines on the radical management of patients with lung cancer

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19